ARCHIVES

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

This article is from The Cancer Letter archive.

Vol. 18 No. 19 | May 8, 1992

Download PDF Visit The Full Archive

Related Articles

Vanderbilt Recruits Sosman To Lead Tumor Immunology.

January 18, 2002

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

February 28, 2014

Caribbean Conference Reports Incidence Differences With U.S.

August 22, 1986

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

Upton May Leave NCI Soon, Newell Accepts Post At M.D. Anderson to Head Cancer Prevention

August 17, 1979